Download PDF
Hamostaseologie 1986; 06(06): 241-247
DOI: 10.1055/s-0038-1655170
Originalarbeiten
Schattauer GmbH

Fettstoffwechselstörungen ein Risikofaktor des zerebralen Insults?

F. Holzner
1   Neurologischen Universitätsklinik Wien (Vorstand: Univ.-Prof. Dr. L. Deecke)
,
K. Zeiler
1   Neurologischen Universitätsklinik Wien (Vorstand: Univ.-Prof. Dr. L. Deecke)
,
L. Deecke
1   Neurologischen Universitätsklinik Wien (Vorstand: Univ.-Prof. Dr. L. Deecke)
,
E. Auff
1   Neurologischen Universitätsklinik Wien (Vorstand: Univ.-Prof. Dr. L. Deecke)
,
Ch. Baumgartner
1   Neurologischen Universitätsklinik Wien (Vorstand: Univ.-Prof. Dr. L. Deecke)
› Author Affiliations
Further Information

Publication History

Publication Date:
25 June 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Bedeutung von Hyperlipoproteinämien als Risikofaktor für zerebrale Durchblutungsstörungen ist umstritten.

In den meisten retrospektiv konzipierten Studien wurden bei Patienten mit klinisch manifesten zerebrovaskulären Ereignissen Störungen des Lipidstoffwechsels festgestellt, vor allem eine Erhöhung der LDLsowie eine Erniedrigung der HDL-Werte.

Hingegen lassen die Ergebnisse der umfangreichen Prospektivstudien keine oder nur partielle Zusammenhänge zwischen Hyperlipoproteinämien und der Manifestation zerebrovaskulärer Erkrankungen erkennen.

In dem vorliegenden Literaturüberblick werden die Ergebnisse der wichtigsten Studien zum Thema vorgestellt, die möglichen Ursachen der differenten Resultate werden diskutiert.

 

  • Literatur

  • 1 Abu-Zeid H A H, Choi N W, Nelson N A. Epidemiologie features of cerebrovascular disease in Manitoba: incidence by age, sex and residence, with etiologic implications. Canad Med Ass J 1975; 113: 379-84.
    PubMedGoogle Scholar
  • 2 Bihari-Varga M, Szekely J, Gruber E. Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease. The influence of various risk factors. Atherosclerosis 1981; 40: 337-45.
    CrossrefPubMedGoogle Scholar
  • 3 Braunsteiner H, Sailer S, Sandhofer E. Störungen des Lipoproteidstoffwechsels. In: Innere Medizin in Praxis und Klinik. Hornbostel H, Kaufmann W, Siegenthaler W. (Hrsg). Teil 13 (Sonderausgabe). Stuttgart-New York: Thieme: 1977. S17, 70-81.
    Google Scholar
  • 4 Bruck J, Fischer M, Tschabitscher H. Über Veränderungen der Serumlipoproteine bei zerebrovaskulären Erkrankungen. Wien klin Wschr 1981; 93: 604-9.
    PubMedGoogle Scholar
  • 5 Bruck J, Fischer M, Sluga E, Tschabitscher H. Apolipoproteine A und B bei zerebrovaskulären Erkrankungen. Nervenarzt 1985; 56: 89-93.
    PubMedGoogle Scholar
  • 6 Candelise L, Bianchi F, Galligoni F, Albanese V, Bonelli G, Bozzao L, Inzitari D, Mariani F, Rasura M, Rognoni F, Sangiovanni G, Fieschi C. Italian multicenter study on reversible cerebral ischemic attacks: III Influence of age and risk factors on cerebrovascular atherosclerosis. Stroke 1984; 15: 379-82.
    CrossrefPubMedGoogle Scholar
  • 7 Chopra J S, Prabhakar S. Clinical features and risk factors in stroke in young. Acta Neurol Scandinav 1979; 60: 289-300.
    PubMedGoogle Scholar
  • 8 Deisenhammer E, Sommer R, Teufl W. Verhältnis der Lipoproteinfraktionen bei ischämischen Hirnerkrankungen (LDL/ HDL). Wien klin Wschr 1982; 94: 42-3.
    PubMedGoogle Scholar
  • 9 Diener H C, Dichgans J, Goth H. Risikofaktoren und Begleiterkrankungen bei Stenosen und Verschlüssen der A. carotis interna. Fortschr Neurol Psychiat 1982; 50: 330-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Dorndorf W. Schlaganfälle. Klinik und Therapie, 2. Aufl. Stuttgart-New York: Thieme: 1983: S7-9.
    Google Scholar
  • 11 Duncan G W, Lees R S, Ojemann R G, David S S. Concomitants of atherosclerotic carotid artery stenosis. Stroke 1977; 08: 665-9.
    CrossrefPubMedGoogle Scholar
  • 12 Fogelholm R, Aho K. Ischaemic cerebrovascular disease in young adults. 2. Serum cholesterol and triglyceride values. Acta Neurol Scandinav 1973; 49: 428-33.
    PubMedGoogle Scholar
  • 13 Fredrickson D S, Lees R S. A system for phenotyping hyperlipoproteinemia. Circulation 1965; 31: 321-7.
    CrossrefPubMedGoogle Scholar
  • 14 Gertler M M, Rusk H A, Whiter H H, Leetma H E, Ehrenkranz M. Ischemic cerebrovascular disease. The assessment of risk factors. Geriatrics 1968; 23: 135-41.
    PubMedGoogle Scholar
  • 15 Glück C J, Daniels S R, Bates S, Benton C, Tracy T, Third J L HC. Pediatric victims of unexplained stroke and their families: familial lipid and lipoprotein abnormalities. Pediatrics 1982; 69: 308-16.
    PubMedGoogle Scholar
  • 16 Gottstein U. Pathogenese und Risikofaktoren der zerebralen Ischämie. Akt neurol 1977; 04: 65-76.
    PubMedGoogle Scholar
  • 17 Haberman S, Capildeo R, Clifford FRose. Risk factors for cerebrovascular disease. In: Advances in Stroke Therapy. Clifford FRose. (ed). New York: Raven Press: 1982: 101-6.
    Google Scholar
  • 18 Heyman A, Karp H R, Heyden S, Bartel A, Cassel J C, Tyroler H A, Hames C G. Cerebrovascular disease in the biracial population of Evans County, Georgia. Arch Intern Med 1971; 128: 949-55.
    CrossrefPubMedGoogle Scholar
  • 19 Hindfelt B, Nilsson O. Brain infarction in young adults. Acta Neurol Scandinav 1977; 55: 145-57.
    CrossrefPubMedGoogle Scholar
  • 20 Kagan A, Popper J S, Rhoads G G, Yano K. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke 1985; 16: 390-6.
    CrossrefPubMedGoogle Scholar
  • 21 Kannel W B. Current status of the epidemiology of brain infarction associated with occlusive arterial disease. Stroke 1971; 02: 295-318.
    CrossrefPubMedGoogle Scholar
  • 22 Kannel W B, Gordon T, Dawber T R. Role of lipids in the development of brain infarction: The Framingham Study. Stroke 1974; 05: 679-85.
    CrossrefPubMedGoogle Scholar
  • 23 Kannel W B, Wolf P A, Verter J. Risk faktors for stroke. In: Stroke and the Extracranial Vessels. Smith R R. (ed.) New York: Raven Press: 1984: 47-58.
    Google Scholar
  • 24 Khaw K-T, Barrett-Connor E, Suarez L, Criqui M H. Predictors of stroke-associated mortality in the elderly. Stroke 1984; 15: 244-8.
    CrossrefPubMedGoogle Scholar
  • 25 Ladurner G, Ott E, Dornauer U, Schreyer H, Lechner H. Lipidstoffwechsel und angiologischer Befund bei der TIA. Nervenarzt 1978; 49: 88-9.
    PubMedGoogle Scholar
  • 26 Landi G, Guidotti M, Pinciroli D, Scialfa G, Morabito A. Reversible ischemic attacks with normal angiogram: risk factors, clinical findings, and prognosis. Neurology 1985; 35: 412-5.
    CrossrefPubMedGoogle Scholar
  • 27 Lin C H, Shimizu Y, Kato H, Robertson T L, Furonaka H, Kodama K, Fukunaga Y. Cerebrovascular diseases in a fixed population of Hiroshima and Nagasaki, with special reference to relationship betweeen type and risk factors. Stroke 1984; 15: 653-60.
    CrossrefPubMedGoogle Scholar
  • 28 Louis S, McDowell F. Stroke in young adults. Ann intern Med 1967; 66: 932-8.
    CrossrefPubMedGoogle Scholar
  • 29 Marshall J. The cause and prognosis of strokes in people under 50 years. J Neurol Sci 1982; 53: 473-8.
    CrossrefPubMedGoogle Scholar
  • 30 Murai A, Tanaka T, Miyahara T, Kameyama M. Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke 1981; 12: 167-72.
    CrossrefPubMedGoogle Scholar
  • 31 Nubiola A R, Masana L, Masdeu S, RubiesPrat J. High-density lipoprotein cholesterol in cerebrovascular disease. Arch Neurol 1981; 38: 468.
    CrossrefPubMedGoogle Scholar
  • 32 Okada H, Horibe H, Ohno Y, Hayakawa N, Aoki N. A prospective study of cerebrovascular disease in Japanese rural communities, Akabane and Asahi. Part 1: Evaluation of risk factors in the occurrence of cerebral hemorrhage and thrombosis. Stroke 1976; 07: 599-607.
    CrossrefPubMedGoogle Scholar
  • 33 Oliver M F. Risks of correcting the risks of coronary disease and stroke with drugs. New Engl J Med 1982; 306: 297-8.
    CrossrefPubMedGoogle Scholar
  • 34 Paterson J C, Armstrong R, Armstrong E C. Seram lipid levels and the severity of coronary and cerebral atherosclerosis in adequately nourished men, 60 to 69 years of age. Circulation 1963; 27: 229-36.
    CrossrefPubMedGoogle Scholar
  • 35 Pearce J, Aziz H. Uric acid and serum lipids in cerebrovascular disease. Part 2: Uric acid plasma lipid correlations I Neurol Neurosurg Psychiat 1970; 33: 88-91.
    PubMedGoogle Scholar
  • 36 Rhomberg H P. Koronare Risikofaktoren in einer ländlichen Bevölkerung und deren Beeinflußbarkeit innerhalb von drei Jahren. Wien klin Wschr 1981; 93 (Suppl. 127) 1-30.
    PubMedGoogle Scholar
  • 37 Robinson R W, Higano N, Cohen W D. Comparison of serum lipid levels in patients with cerebral thrombosis and in normal subjects. Ann intern Med 1963; 59: 180-5.
    CrossrefPubMedGoogle Scholar
  • 38 Rössner S, Kjellin K G, Mettinger K L, Siden A, Söderström C E. Normal serumcholesterol but low HDL-cholesterol concentration in young patients with ischaemic cerebrovascular disease. Lancet 1978; I: 577-9.
    PubMedGoogle Scholar
  • 39 Salonen J T, Puska P, Tuomilehto J, Homan K. Relation of blood presssure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland. Stroke 1982; 13: 327-33.
    CrossrefPubMedGoogle Scholar
  • 40 Schonau FJorgensen, Dyerberg J, Hjorne N, Ewald J. Plasma lipids and lipoproteins in young patients with brain infarction. Acta Neurol Scand 1978; 57: 432-7.
    PubMedGoogle Scholar
  • 41 Soelberg PSorensen, Boysen G, Jensen G, Schnohr P. Prevalence of stroke in a district of Copenhagen. The Copenhagen City Heart Study. Acta Neurol Scandinav 1982; 66: 68-81.
    PubMedGoogle Scholar
  • 42 Steinmann B. Zur Pathogenese der Apoplexie im Alter unter 50 Jahren. Schweiz Med Wschr 1969; 99: 1098-106.
    PubMedGoogle Scholar
  • 43 Stemmermann G N, Hayashi T, Resch J A, Chung C S, Reed D M, Rhoads G G. Risk factors related to ischemic and hemorrhagic cerebrovascular disease at autopsy: The Honolulu Heart Study. Stroke 1984; 15: 23-8.
    CrossrefPubMedGoogle Scholar
  • 44 Stolley P D, Kuller L H, Nefzger M D, Tonascia S, Lilienfeld A M, Miller G D, Diamond E L. Three-area epidemiological study of geographic differences in stroke mortality. Stroke 1977; 08: 551-7.
    CrossrefPubMedGoogle Scholar
  • 45 Tanaka H, Tanaka Y, Hayashi M, Ueda Y, Date C, Baba T, Shoji H, Horimoto T, Owada K. Secular trends in mortality for cerebrovascular diseases in Japan, 1960 to 1979. Stroke 1982; 13: 574-81.
    CrossrefPubMedGoogle Scholar
  • 46 Tanaka H, Ueda Y, Hayashi M, Date C, Baba T, Yamashita H, Shoji H, Tanaka Y, Owada K, Detels R. Risk Factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982; 13: 62-73.
    CrossrefPubMedGoogle Scholar
  • 47 Terrence C F, Rao G R. Triglycerides as a risk factor in extracranial atherosclerotic cerebrovascular disease. Angiology 1983; 34: 452-60.
    CrossrefPubMedGoogle Scholar
  • 48 Tschinkel M, Ladurner G, Hollasek A, Schreyer H, Lechner H. Hyperlipidämie und angiographischer Befund bei ischämischem Insult. Nervenarzt 1985; 56: 94-7.
    PubMedGoogle Scholar
  • 49 Turnheim M, Havelec L, Heiss W-D, Summer K. Eigenarten ischämischer Insulte bei jungen Erwachsenen. Wien klin Wschr 1977; 89: 106-10.
    PubMedGoogle Scholar
  • 50 Van Merodé T, Hick P, Hoeks A P G, Renemann R S. Serum HDL/total cholesterol ratio and blood pressure in asymptomatic atherosclerotic lesions of the cervical carotid arteries in men. Stroke 1985; 16: 34-8.
    CrossrefPubMedGoogle Scholar
  • 51 Whisnant J P. The decline of stroke. Stroke 1984; 15: 160-8.
    CrossrefPubMedGoogle Scholar
  • 52 Wolf P A. Risk factors for stroke. Stroke 1985; 16: 359-360.
    CrossrefPubMedGoogle Scholar
  • 53 Wolf S M. Dietary cholesterol, atherosclerosis, and strokes. Neurology 1982; 32: 1408.
    CrossrefPubMedGoogle Scholar
  • 54 Yatsu F M. Dietary cholesterol: does it aggravate strokes due to atherosclerosis?. Neurology 1981; 31: 1535-6.
    CrossrefPubMedGoogle Scholar